Showing results (441-450 of 630) with videos related to

Sort By:
Pageof 63
Journal of Cellular Physiology|June 26, 2001
Pigment epithelium-derived factor inhibits retinal and choroidal neovascularizationK Mori, E Duh, P Gehlbach, et al.
American Journal of Ophthalmology|September 24, 2013
Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusionRaafay Sophie, Gulnar Hafiz, Adrienne W Scott, et al.
Seminars in Arthritis and Rheumatism|January 18, 2025
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based studyGiacomo De Luca, Maria De Santis, Veronica Batani, et al.
Angiogenesis|October 25, 2013
Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-AAling Dong, Christopher Seidel, Daniel Snell, et al.
Journal of Cellular Physiology|April 20, 2004
Intraocular gutless adenoviral-vectored VEGF stimulates anterior segment but not retinal neovascularizationYuji Oshima, Kyoichi Takahashi, Sachiko Oshima, et al.
Nano Letters|October 26, 2011
Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lungMatthew C Duch, G R Scott Budinger, Yu Teng Liang, et al.
Ophthalmology|April 5, 2011
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edemaPeter A Campochiaro, David M Brown, Andrew Pearson, et al.
Annals of the Rheumatic Diseases|March 28, 2014
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester diseaseMaria Giulia Cangi, Riccardo Biavasco, Giulio Cavalli, et al.
Seminars in Arthritis and Rheumatism|March 2, 2024
A multi-national survey to identify clinicians' perspectives concerning Proton Pump inhibitors in patients with systemic sclerosisGiulia Bandini, Alessia Alunno, Filipe Oliveira Pinheiro, et al.
Human Gene Therapy|February 4, 2006
Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trialPeter A Campochiaro, Quan Dong Nguyen, Syed Mahmood Shah, et al.
Pageof 63